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Abstract 35 
Purpose Hypoxia has been shown to reduce energy intake and lead to weight loss, 36 
but the underlying mechanisms are unclear. The aim was therefore, to assess 37 
changes in eating after rapid ascent to 4559 m and to investigate to what extent 38 
hypoxia, acute mountain sickness (AMS), food preferences, and satiation hormones 39 
influence eating behavior. 40 
Methods Participants (n=23) were studied at near sea level (Zurich (ZH), 446 m) and 41 
on two days after rapid ascent to Capanna Margherita (MG) at 4559 m (MG2 and 42 
MG4). Changes in appetite, food preferences and energy intake in an ad libitum meal 43 
were assessed. Plasma concentrations of cholecystokinin, peptide tyrosine-tyrosine, 44 
gastrin, glucagon and amylin were measured. Peripheral oxygen saturation (SpO2) 45 
was monitored and AMS assessed using the Lake Louis score. 46 
Results Energy intake from the ad libitum meal was reduced on MG2 compared to 47 
ZH (643±308 kcal vs 952±458 kcal, p=0.001), but was similar to ZH on MG4 48 
(890±298 kcal). Energy intake on all test days was correlated with hunger/satiety 49 
scores prior to the meal and AMS scores on MG2 but not with SpO2 on any of the 50 
three days. Liking for high-fat foods before a meal predicted subsequent energy 51 
intake on all days. None of the satiation hormones showed significant differences 52 
between the three days.  53 
Conclusion Reduced energy intake after rapid ascent to high altitude is associated 54 
with AMS severity. This effect was not directly associated with hypoxia or changes in 55 
gastrointestinal hormones. Other peripheral and central factors appear to reduce 56 
food intake at high altitude.  57 
Key words: hypoxia; dietary intake; food preferences; high altitude; acute mountain 58 
sickness 59 
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 60 
Introduction 61 
Millions of people travel to high or very high altitudes (>2500 meters above sea level) 62 
every year enjoying trekking, climbing, skiing or for work and this has stimulated 63 
interest in high altitude medicine dealing with the effects of hypoxia on human 64 
physiology. Nutritional scientists have observed a reduction in energy intake and 65 
weight loss in healthy mountaineers in conditions of low oxygen availability [14, 25, 66 
29, 38]. Similar effects have been documented in respiratory disease occurring at 67 
sea level. Persistent hypoxia in this patient group is associated with reduced energy 68 
intake, weight loss and poor disease outcomes [7]. Moreover, the clinical relevance 69 
of hypoxia independent of disease severity as a cause of these problems is 70 
supported by the finding that oxygen supplementation leads to weight gain in Chronic 71 
Obstructive Pulmonary Disease [3]. 72 
The partial pressure of oxygen in inspired air falls from about 150 mmHg at sea level 73 
to 84 mmHg at 4559 m (elevation of Capanna Margherita, the highest scientific 74 
research station in Europe). At the same time the incidence of acute mountain 75 
sickness (AMS) increases from about 8% below 4000 m up to 40% at 4559 m [24]. 76 
Affected patients complain of gastrointestinal symptoms such as anorexia, nausea 77 
and vomiting as well as headache, malaise and trouble sleeping [30]. Despite the 78 
association between the two factors, the relative importance of hypoxia per se and 79 
AMS as a cause of disturbed eating has not been established. Further, the 80 
association between energy intake and the severity of AMS is not consistent [25].  81 
Several factors have been proposed to cause reduced eating in hypoxia and AMS. 82 
Most refer to central neurological effects such as cerebral edema in AMS [37, 38]; 83 
peripheral, gastrointestinal factors, such as alteration in the secretion of  84 
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neuroendocrine gastrointestinal and pancreatic hormones [1, 11, 20, 32, 41], may 85 
however also be important. 86 
 87 
Additionally, alterations in food preferences may influence eating behavior at high 88 
altitude. Eating is generally controlled by two complementary systems. Homeostatic 89 
pathways increase the motivation to eat and restore energy balance in case of 90 
depleted energy stores. Hedonic, reward-based mechanisms, however, can override 91 
homeostatic controls through cravings or increased desire to eat highly palatable 92 
foods [19]. In animal studies hypoxia decreased the 'incentive' to consume food 93 
rather than changing 'hunger' or 'appetite', thus shifting the taste spectrum toward 94 
'unpalatable' for a given diet [8]. 95 
The primary aim of this study was to assess changes in food intake and preferences 96 
in healthy human subjects after rapid ascent from 446 m to 4559 m and to assess the 97 
roles of hypoxia, AMS, and satiation hormones in these changes.  98 
 99 
Subjects and methods 100 
Subjects 101 
Thirty-two healthy, experienced mountaineers (20 – 60 years old) were recruited by 102 
posting adverts in alpine journals and by screening the “Contact list of rescued 103 
people for high altitude disease” of the last five years of the Air Zermatt (Switzerland). 104 
This procedure ensured that the study population was enriched by volunteers with 105 
experience of or susceptibility to AMS and high altitude pulmonary edema (HAPE) 106 
[22]. Sample size calculation for the entire study was based on the pulmonary 107 
outcomes. However, for this sub-study it was estimated that, with a power of 90% 108 
and an α-error of 0.05, a sample size of 21 subjects would be sufficient to detect 109 
differences in food intake between days (sample size calculation based on [25, 38]). 110 
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Exclusion criteria were: more than three nights above 2500 m in the month preceding 111 
study entry; chronic diseases necessitating regular medication such as arterial 112 
hypertension, coronary heart disease and pulmonary hypertension; patients with 113 
malignancy, transplant patients, patients with clinically significant heart valve disease 114 
or with congenital heart or lung disease; lactose intolerance, celiac disease or 115 
relevant food allergies or specific food requirements (e.g. vegetarians, Kosher) that 116 
could not be provided in the mountain hut. The study was approved by the Ethics 117 
Committee of the Canton of Zurich (EK-1677). Written informed consent was 118 
received from all subjects. 119 
 120 
Study design 121 
This study represents the nutritional science arm of a larger body of work. Other 122 
results (e.g. sleep studies, exercise capacity, lung function, lipid metabolism, gastric 123 
emptying) will be reported elsewhere. All examinations were carried out at low 124 
(Zurich, 446 m above sea level, ZH) and high altitude (Capanna Margherita, 4559 m 125 
above sea level, MG). For the low altitude examinations subjects arrived in the late 126 
afternoon at the University Hospital Zurich for the sleep studies with other 127 
examinations carried out on the following day. For the high altitude examinations 128 
participants ascended on day 0 by cable car from Alagna Valsesia (1200 m, Italy) to 129 
about 2980 m and then hiked to the Rifugio Gniffeti at 3650 m where they spent one 130 
night. On day 1 (MG1), the participants climbed to Capanna Margherita at 4559 m. 131 
Nutritional studies followed on day 2 (MG2) and day 4 (MG4).  132 
All instruments used for the study were tested for functionality at high altitude in a 133 
pressure chamber prior to the ascent to Capanna Margherita. 134 
 135 
Study Protocol 136 
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The schedule of meals and other study procedures is presented in Figure 1. On the 137 
morning of each test day, an arterial and venous catheter were placed in the forearm 138 
for blood sampling. Thereafter, unsedated ultra-fine transnasal 139 
oesophagogastroduodenoscopy was performed to examine the stomach and the 140 
duodenum (results to be presented elsewhere). After a standardized breakfast lung 141 
function tests, a maximal exercise capacity test on a cyclo-ergometer and 142 
echocardiography at rest and during moderate exercise were performed (to be 143 
presented elsewhere). Nutritional examinations were all done in the afternoon after 144 
the subjects had time to relax. Peripheral oxygen saturation (SpO2) was monitored 145 
by pulse oximetry (fingerclip measurement using Infinity by Dräger, Liebefeld, 146 
Switzerland) and repetitive arterial blood gas analysis (AVL 5 Radiometer, 147 
Copenhagen, Denmark). 148 
 149 
Food intake 150 
To control for differences in food intake before the low- and high altitude 151 
examinations, subjects were asked to fill in a weighed food record for four days prior 152 
to the tests [12]. For each subject the amount of calories given for breakfast was 153 
calculated to meet 30% of their energy requirements based on medium physical 154 
activity [16]. During the day, subjects consumed a fixed energy meal of two muffins 155 
(total of 400 kcal; 35% fat, 10% protein, 54% carbohydrates). Four hours later, 156 
subjects completed a food preference questionnaire (see below) and then consumed 157 
again two similar muffins as a preload before an ad libitum dinner 90 min later. For 158 
dinner, subjects were offered pasta, bolognese sauce, grated parmesan cheese and 159 
two sorts of biscuits. They were free to choose what and how much they ate; all food 160 
consumed was weighed to the nearest gram on a kitchen scale by one of the 161 
examiners. After dinner, subjects completed a food preference questionnaire as 162 
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before. After the preload, before and after the dinner, hunger and satiety scores 163 
(hunger, desire to eat, amount of food that could be eaten at the moment) as well as 164 
gastrointestinal symptoms (feeling of stomach distension and nausea) were 165 
assessed on a 100 mm visual analogue scale anchored by the statements “not at all” 166 
and “extremely”. Unsweetened tea and water were available ad libitum throughout all 167 
examination days. 168 
 169 
Food preferences 170 
To assess food preferences, a modified hedonic analysis tool was used [9]. Twenty 171 
food stimuli were presented to the subjects as color photographs. The food items 172 
were assigned to four different categories: high-fat sweet, low-fat sweet, high-fat 173 
savory and low-fat savory. Low-fat food was characterized by less than 25%, and 174 
high-fat foods by more than 50% of the energy derived from fat. The different food 175 
stimuli used are listed in Table 1. 176 
 177 
The assessment of liking (expected liking of each food image category) and relative 178 
food preference (non-verbal, motivated choice between food categories) was 179 
adapted from Finlayson et al. [9]. For the ‘liking’ measurement all 20 food items were 180 
rated on 100 mm visual analogue scales (‘How pleasant would you find the taste of 181 
this food at the moment?’). For assessment of ‘relative preference’ forced choice 182 
methodology was used: food items from different categories were presented in pairs 183 
over a series of trials and subjects had to choose ‘Which of those foods would you 184 
prefer to eat at the moment?’ A total of 60 randomly selected combinations balanced 185 
within food categories were used. Food preferences were assessed in a hungry (four 186 
hours after fixed energy lunch) and in a satiated state (after ad libitum dinner). 187 
 188 
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 189 
Blood sampling 190 
A total of nine venous blood samples was taken in EDTA tubes for assessment of 191 
gastrointestinal hormones starting with a fasting sample on waking and followed by 192 
samples just before consumption of the muffin lunch as well as 30, 60, 90, 120, 180 193 
and 240 min thereafter until the ad libitum dinner. All blood samples were centrifuged 194 
immediately and the plasma was stored at -80°C (in freezers at low altitude and in 195 
liquid nitrogen at high altitude as well as during transport). Arterial blood for gas 196 
analysis was taken during lung function test but not later during the test meal. Before 197 
the ad libitum meal the SpO2 was measured. 198 
 199 
Acute mountain sickness 200 
AMS scores were determined on each test day in the Capanna Margherita based on 201 
the Lake Louise scoring (LLS) system with five rating questions with levels between 0 202 
and 3 (headache, gastrointestinal symptoms, fatigue or weakness, dizziness/light-203 
headedness and difficulty sleeping) and the condition was diagnosed based on the 204 
scores as well as repeated clinical examinations. A total score > 5 indicated AMS [23, 205 
28].  206 
 207 
Medication 208 
Participants who developed severe AMS (Lake Louise score > 5) or had a history of 209 
high altitude pulmonary edema (HAPEs) were treated with 2x8 mg/day 210 
Dexamethasone (9-Fluor-16a-methylprednisolone, Dexamethasone 4 mg, 211 
Galepharm, Küsnacht, Switzerland) starting in the evening of the first examination 212 
day (MG2; i.e. after the completion of all tests on MG2) until descent. Minor 213 
symptoms like moderate headache and nausea were treated with analgesics 214 
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(Dafalgan®, Paracetamol). Gastrointestinal ulcer and reflux lesions were medicated 215 
with Nexium® (Esomeprazole). Diagnosis and prescription of medication were 216 
conducted by medical doctors (MM, OG, HF). 217 
 218 
Laboratory analysis 219 
Analyses were carried out on plasma samples. Active amylin and glucagon were 220 
measured using hormone kits from Millipore Corporation (Milliplex® MAP Human 221 
Endocrine Assay, Millipore, Billerica, MA, USA); CCK-8 (active), PYY 1-36 and PYY 222 
3-36 (truncated form) were measured using radioimmunoassay (RIA) Kits 223 
(Eurodiagnostica, Burgdorf, Switzerland) by Prof Christoph Beglinger, University 224 
Hospital Basel; gastrin and EPO were measured using immunoassays (Human 225 
Gastrin I (1-17), Enzo Life Sciences, Lausen, Switzerland; Human Erythorpoietin, 226 
Quantikine, R&D Systems, Abingdon, UK). 227 
 228 
Data analysis 229 
Data were analyzed using SPSS Statistics 17.0 (SPSS Chicago, IL, USA) and Graph 230 
Pad Prism Version 5.0 (San Diego, CA, USA). The Kolmogorov-Smirnov test was 231 
used to test data for normal distribution. Where normal distribution could not be 232 
assumed (nausea, feeling of distention), the non-parametric Wilcoxon test was used 233 
to test for differences between the different days. For normally distributed data, group 234 
comparisons were carried out using t-tests (unpaired or paired, as appropriate) and 235 
one-way ANOVA. For comparisons of hormone levels between days and time points, 236 
two-way ANOVA with post hoc Bonferroni correction was applied. Area under the 237 
curve (AUC) was calculated for the hormones using Graph Pad Prism with the 238 
concentrations ‘before muffin’ taken as baseline. For food preference data, a general 239 
linear model was used with a Bonferroni post hoc test. Multiple linear regression 240 
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models were carried out to analyze the impact of food preferences on energy intake. 241 
Dietary intake data was analyzed using the nutrition software EBISpro for Windows 242 
8.0 (J. Erhardt, University of Hohenheim, Germany) including foods specific to 243 
Switzerland. 244 
 245 
Results 246 
Of the 32 subjects recruited, three withdrew informed consent before the baseline 247 
examination, three withdrew it after the baseline examinations in Zurich and one was 248 
excluded due to illness at the baseline examination. Thus 25 subjects (10 females, 249 
15 males; age 43.8 ± 9.5 years (range 22-60); BMI 23.8 ± 2.2kg/m2 (range 20.2-250 
31.4)) completed the study under all conditions. One subject did not finish meals and 251 
nutritional questionnaires during the baseline examination and two subjects were 252 
delayed in their ascent the Capanna Margherita due to bad weather and did therefore 253 
not participate in the nutritional surveys on MG2 (excluded from analysis). Thus, data 254 
of 22 subjects was available for nutritional analysis. Due to a food shortage at the 255 
Capanna Margherita during a spell of bad weather and thus no air transport, no 256 
cheese was available for the ad libitum meal for seven participants; no macronutrient 257 
analysis was conducted for this group. 258 
 259 
Hypoxia and AMS 260 
As expected, ascent to 4559 m caused significant hypoxemia which was partially 261 
reversed by acclimatization and/or the intake of dexamethasone at MG4 (Table 2). 262 
After consumption of the preload muffins on MG2 AMS was found in nine participants 263 
(39%). Although patients with the most severe decrease in arterial oxygenation on 264 
MG2 tended to have more AMS symptoms and signs, there was no significant 265 
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correlation between LLS score and oxygen pressure (PaO2) (r=0.15, p=0.494) and 266 
arterial oxygen saturation (SaO2) (r=0.12, p=0.56).  267 
Effects of dexamethasone on LLS, PaO2, PaCO2 as well as O2 saturation are 268 
shown in Table 2. While LLS was significantly different between treated and non-269 
treated groups on MG2, none of the other variables were. Following treatment with 270 
dexamethasone all nine participants recovered from AMS on MG4. Among non-271 
HAPEs one without AMS at MG2 developed the condition at MG4. A mild HAPE 272 
without simultaneous AMS was diagnosed in a HAPEs participant at MG3. This 273 
subject was treated with tadalafil (20mg/day) on MG4 until descent.  274 
 275 
Food intake 276 
Based on the analysis of the weighed food records baseline food intake did not differ 277 
at the time just before low and high altitude examinations (data not shown). 278 
Mean energy intake (±SD) from the ad libitum dinner on the three examination days 279 
was ZH: 952±458 kcal, MG2: 643±308 kcal and MG4: 890±298 kcal. Energy intake 280 
was lower on MG2 compared to ZH (p=0.001), but approached the baseline level on 281 
MG4 (p=0.410 compared to ZH). The absolute amount of all macronutrients eaten 282 
during the ad libitum dinner was reduced on MG2 compared to baseline (p<0.05), but 283 
the energy distribution from macronutrients did not change (protein: ZH 19%, 284 
MG2=19%; carbohydrates: ZH=51%, MG2=53%; fat: ZH=30%, MG2=29%). 285 
However, on MG4 the proportion of total energy intake from carbohydrates was 286 
reduced (48%) compared to both ZH and MG2, and that of fat was increased (33%; 287 
p<0.05). Mean energy intake (±SD) at breakfast on all study days was 718±95 kcal 288 
and each subject consumed two times two muffins, which amounted to a total calorie 289 
intake of 800 kcal. Thus, the ad libitum dinner contributed 39, 30 and 37% of total 290 
energy intake at ZH, MG2 and MG4, respectively. 291 
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 292 
Hunger/satiety scores 293 
The hunger/satiety scores are shown in Table 3. The three scores for ‘hunger’, 294 
‘desire to eat’ and ‘which amount of food could you eat right now?’ given before the 295 
meal all correlated positively with the actual energy intake during the meal and on all 296 
three days (all p<0.01). While the hunger/satiety ratings before the ad libitum meal 297 
were lower on MG2 than in ZH and increased back to baseline on MG4, the ratings 298 
given after the meal did not change significantly between ZH and MG2, but were 299 
higher on MG4 compared to MG2 (p<0.05). Total energy intake was negatively 300 
correlated with AMS scores on MG2 (p=0.043, r=-0.468), but not on MG4, and it was 301 
not correlated with sO2 on any of the study days. Similarly, in a stepwise multiple 302 
regression, the only significant predictor for energy intake on MG2 was AMS (LLS 303 
p=0.042, β=-0.471). BMI, age, gender and sO2 were not significant. 304 
 305 
Effect of Dexamethasone on energy intake 306 
In total, 11 subjects were treated with dexamethasone on the evening of MG2 (nine 307 
with AMS and two HAPEs without AMS). Energy intake was lower at baseline in ZH 308 
in those subjects who later received Dexamethasone treatment for AMS and/or 309 
HAPE susceptibility after study procedures on MG2 (treated 712 ± 382 kcal vs. 310 
untreated: 1192 ± 410 kcal; p=0.010), but the pattern of change over the days was 311 
similar in both groups (Figure 2). Energy intake was also lower on MG2 in the 312 
subjects that had to be treated with dexamethasone (treated 501 ± 243 kcal vs. 313 
untreated 802 ± 306 kcal; p=0.029; note: treatment started only after the ad libitum 314 
dinner on that day), but it did not differ between groups on MG4 (treated 817 ± 283 315 
kcal vs. untreated 964 ± 307 kcal; p=0.255). Acclimatization and Dexamethasone 316 
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treatment significantly contributed to increase energy intake from MG2 to MG4 317 
(p=0.006 in the non treated, p=0.015 in the treated subjects). 318 
 319 
Food preferences 320 
Liking 321 
Liking scores of the different food categories (high-fat, low-fat, sweet and savory) are 322 
presented in Table 4. Liking for high-fat, low-fat and savory foods was significantly 323 
increased on MG4 compared to MG2 (p<0.05); the difference between MG4 and ZH 324 
was only significant for savory foods (p<0.05). For sweet foods, no significant 325 
differences were detected between days. A negative correlation of liking scores for 326 
low-fat and savory foods on MG2 (pre meal) with AMS was present (p=0.009, r=-327 
0,569 and p=0.013, r=-0.546, respectively), while none of the scores were related to 328 
AMS on MG4. 329 
A stepwise multiple regression model was used to investigate the effect of liking of 330 
the different food categories and it revealed that for all days, liking for high-fat foods 331 
was a predictor of total energy intake (ZH: p<0.001, b=0.763, R2=0.582; MG2: 332 
p=0.008, b=0.588, R2=0.346 and MG4: p=0.012, b=0.527, R2=0.277) while all other 333 
food categories and Dexamethasone were not significant predictors. 334 
 335 
Relative preference 336 
The mean frequencies of food choices for the four categories are shown in Table 4. 337 
For all categories, frequencies did not differ between the days, but they differed 338 
between pre and post meal (p<0.01). For high-fat and sweet foods, the frequency 339 
increased after food intake while it decreased for low-fat and savory food on all days. 340 
Further, a significant positive association between sweet frequency (pre meal) and 341 
AMS was seen on MG2 (p=0.044, r=0.466). 342 
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To assess the relationship between measures of food choice and energy intake, two 343 
independent composite scores were created: relative taste preference: sweet 344 
frequency – savory frequency; relative macronutrient preference: high-fat frequency – 345 
low-fat frequency. Stepwise multiple regression models revealed that relative 346 
preference measures and dexamethasone treatment were not predictors of energy 347 
intake on any of the days.  348 
 349 
Gastrointestinal and pancreatic hormones 350 
Blood samples were not available on all days from four of the 25 subjects. The 351 
plasma concentrations of glucagon, amylin, peptide tyrosine tyrosine (PYY) and 352 
cholecystokinin (CCK) on the different study days and time points are presented in 353 
Figure 3. No significant changes in plasma glucagon or gastrin concentrations were 354 
observed in response to food intake or on the different days. Plasma amylin, PYY 355 
and CCK increased postprandially but did not differ between days.  356 
Overall altitude increased amylin and PYY (p<0.05), but there were no significant 357 
effects for individual differences between days at any time point. Except for glucagon 358 
and CCK, the area under the curve (AUC) throughout the postprandial period did not 359 
significantly differ between days for any of the hormones.  360 
Glucagon output was decreased postprandially (negative AUC’s) and the AUC for 361 
240 min was significantly smaller on MG4 compared to ZH (p=0.023). Furthermore, 362 
in the immediate (60 min) postprandial period the AUC for glucagon was smaller on 363 
MG2 compared to ZH (p=0.043), whereas the difference between MG4 and ZH was 364 
not significant. The short term response (30 min and 60 min) of CCK was greater on 365 
MG4 compared to ZH (p<0.05), but there was no difference between ZH and MG2. 366 
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A non-significant trend was observed for amylin to be increased on MG2 throughout 367 
the postprandial phase and for PYY to be reduced on MG2 in the early postprandial 368 
phase. 369 
 370 
Discussion 371 
This study presents a detailed assessment of dietary intake and dietary preferences 372 
with measurements of gastrointestinal and pancreatic hormones in 22 healthy human 373 
subjects on exposure to acute hypoxia following rapid ascent from 446 m to 4559 m. 374 
As expected, a marked decrease in oxygen saturation indicative of severe hypoxia 375 
was present after rapid ascent to high altitude with a fall in sO2 from 97% at low 376 
altitude to 76% on the first day at high altitude. At the same time 39% of the 377 
participants experienced AMS symptoms that required treatment with 378 
dexamethasone. The findings demonstrate that rapid ascent to high altitude 379 
influences eating behavior in several different ways. Compared to the baseline 380 
examination in Zurich (ZH), results for the first day examination at high altitude (MG2) 381 
showed 1) a significant reduction of energy intake by 33% in the ad libitum meal, 2) 382 
reduced hunger and desire to eat scores and increased satiety ratings, which 383 
correlated with the reduced energy intake, and 3) altered food preferences where 384 
liking for all except sweet foods was reduced. 385 
 386 
Energy intake 387 
The reduced energy intake at 4559 m confirms previous findings at similar altitudes 388 
where both males and females were shown to reduce their energy intake by more 389 
than 30% after ascent to 4300 - 5100 m [15, 21, 33, 40]. The present study extends 390 
these findings by providing a systematic analysis of certain factors that may 391 
contribute to the energy intake reducing effect of hypoxia following rapid ascent to 392 
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high altitude. These include the presence of AMS symptoms and changes in baseline 393 
or postprandial release of neuroendocrine gastrointestinal hormones that influence 394 
energy intake and gastrointestinal function.  395 
We demonstrated that energy intake on MG2 was reduced and negatively correlated 396 
with AMS scores. Interestingly, not only scores above the threshold for diagnosis of 397 
AMS but even subclinical scores of AMS were associated with energy intake; this 398 
can also be seen by the fact that energy intake was reduced to a similar extent in 399 
both the treated and the non-treated groups. Energy intake returned to near normal 400 
levels on MG4, when also the association with AMS scores was no longer present. 401 
Differences between MG2 and MG4 can not be attributed only to acclimatization as 402 
48% of subjects were treated with Dexamethasone after study procedures ended on 403 
the evening of MG2.  Nevertheless, acclimatization or adaptation appears to play an 404 
important role as the day by day increase in energy intake was also observed in the 405 
non-treated group. This is in agreement with previous studies which have shown that 406 
subjects can learn to eat adequate amounts and that this can, during a longer 407 
exposure, prevent or at least attenuate excessive weight loss [4]. In contrast to AMS 408 
scores, there was no direct association between hypoxemia and energy intake on 409 
any study day. Thus reduced energy intake after rapid ascent to high altitude may not 410 
be determined by hypoxia per se, but rather by the individual’s susceptibility to AMS. 411 
Only one previous study reported on the association between AMS and energy 412 
intake and found no significant correlation [25]. In this study, however, the sample 413 
size was very small (7 subjects) and they trekked to 4700 m within 10 days as 414 
compared to the 2 days in our study. The slower ascent may have allowed for 415 
gradual acclimatization and thus a different response to hypoxia.  416 
 417 
Food preferences 418 
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We also studied changes in food preferences that may be associated with reduced 419 
eating in hypoxic conditions at high altitude, an assessment that, to our best 420 
knowledge, was never done in this form before. Liking ratings for high-fat foods 421 
assessed before the meal were good predictors for energy intake, independent of 422 
day and altitude; however, neither changes in liking nor changes in relative food 423 
preference ratings were predictors for changes in total energy intake from baseline to 424 
high altitude. Thus, overall, food preference is not the major cause of reduced energy 425 
intake at high altitude although it may have some impact. There were however 426 
significant effects on specific food items. Palatability (liking) of all food items except 427 
for sweet food was reduced after a meal at baseline and at high altitude. This 428 
confirms that the strong hedonic response induced by sweet foods may override 429 
homeostatic signals of satiety [9]. More interestingly, and in contrast to previous 430 
studies [27, 31], we also noted a significant increase in the palatability of savory 431 
foods at high altitude and an interaction between food preferences and susceptibility 432 
to AMS. This increase may be related to sodium depletion after three days exertion 433 
at high altitude. Sodium depletion in humans and rats leads to an increased 434 
palatability of salt [2, 34] and it is known that ascent to high altitudes leads to sodium 435 
diuresis linked to a suppression of the renin-angiotensin-aldosteron system [42]. This 436 
effect was weaker in patients with AMS. Indeed there was a positive correlation 437 
between the frequency for sweet foods and a negative correlation for savory foods 438 
with AMS scores on MG2. Thus, in contrast to subjects that remain well at altitude, 439 
subjects that develop AMS seem to prefer sweet foods over savory foods. These 440 
effects may be mediated through homeostatic mechanisms involving renin-441 
angiotensin-aldosteron system that control sodium balance. Such mechanisms also 442 
have been linked to performance at altitude and survival on intensive care [26]. In 443 
consequence, during expeditions to high altitude, individual food choices may reflect 444 
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underlying physiologic adaptation to hypoxia and may, potentially, influence the 445 
likelihood of developing AMS. 446 
 447 
Gastrointestinal neuroendocrine hormones 448 
The release of anorexigenic neuroendocrine hormones such as glucagon, amylin 449 
CCK and PYY from the gastrointestinal tract after a meal is considered to play a key 450 
role in meal-ending satiation [10], but their role in reduced eating at high altitude is 451 
less clear. Results for glucagon are contradictory; whereas an animal study in rats 452 
demonstrated increased glucagon secretion under hypoxic conditions (simulated 453 
altitude of 5000 m) [6], a human study found decreased concentrations at high 454 
altitudes (7134 meters) [5]. In our study there was no change in glucagon plasma 455 
levels between baseline and high altitude on MG2 or on MG4. We also observed no 456 
significant increase in the postprandial glucagon concentration and no differences 457 
between test days. These negative results may be due to the relatively low protein 458 
content of the muffin lunch (400 kcal, 9.9 g protein) which may be below the level 459 
required to stimulate a substantial glucagon release [17]. Indeed, against our 460 
expectations, postprandial AUC for glucagon were even negative, indicating a 461 
decrease in glucagon secretion after food intake on all examination days. This 462 
argues against a major role of glucagon in reduced eating during the ad libitum 463 
dinner on MG2, although the limitations noted above apply. 464 
The anorexigenic hormone CCK has been shown to be increased in human subjects 465 
on the second day after ascent to 5100 m [1]; this increase has been linked to the 466 
hypoxia-inducible factor (HIF) [1, 13]. In contrast to these findings, we did not see 467 
significant differences in plasma CCK concentrations between samples taken at 468 
baseline in Zurich and on any of the two days at high altitude. Of note, even though 469 
the altitude was similar in both studies, the duration of ascent varied considerably. 470 
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While our subjects ascended to 4559 meters in only two days, the subjects in the 471 
other study climbed to 5100 meters in 20 days, providing much more time for 472 
acclimatization not only to hypoxia but also to exertion. Interestingly, the AUCs for 473 
CCK, indicative of total CCK output, were significantly higher on MG4 in the early 474 
postprandial phase (0-30 or 0-60 min), whereas there was no change on MG2. 475 
Because eating was significantly reduced on MG2, where no change in CCK was 476 
observed, but not on MG4, it seems unlikely that altered CCK secretion contributed 477 
to the changes in food intake in this setting. 478 
The contribution of PYY, amylin or gastrin to reduced eating in hypoxic conditions 479 
has not been studied previously. Similar to glucagon and CCK, all three hormones 480 
are implicated in the control of energy intake; however, no significant differences in 481 
any of these hormones were observed between the three examination days. Further, 482 
there were no significant differences in the AUCs between test days for amylin and 483 
PYY, neither over the entire postprandial period nor for shorter time intervals. 484 
Overall, it therefore appears unlikely that changes in the secretion of the 485 
neuroendocrine hormones studied here are involved in the reduced dietary intake 486 
documented after rapid ascent to 4559 meters. 487 
 488 
Limitations of this study include difficulty differentiating the effect of hypoxia on eating 489 
behavior from the effect of exertion. Subject activity on ZH, MG2 and MG4 test days 490 
was tightly controlled, but there was no equivalent prior to the ZH test day to the 491 
rapid ascent to high altitude on MG1. Nevertheless, even though a short-term 492 
reduction in hunger and energy intake has been observed directly following intense 493 
exercise [39], the normal longer term response to physical activity is to increase 494 
energy intake [36] and the opposite was observed on MG2. Thus, if anything, the 495 
results may underestimate the effects of hypoxia on appetite and energy intake. 496 
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Similar to most nutritional studies forced eating patterns were applied and the size of 497 
muffin test meals was not adapted to the energy requirements of the subjects. 498 
Furthermore, the muffin meal may not have been adequate to provoke normal 499 
postprandial changes in gastrointestinal hormones and the sample size may have 500 
been too small, as certain non-significant trends were observed. Finally, the use of 501 
Dexamethasone in some study participants certainly affected results on MG4. Due to 502 
ethical concerns, it was not possible to randomize subjects into treated and non-503 
treated groups during a 5 days stay at 4559 m; all subjects showing severe AMS 504 
symptoms on the evening of MG2 were treated. It is important to mention, however, 505 
that only one participant required steroid treatment prior to the measurements on 506 
MG2 and that the analysis found similar trends in each sub-group. 507 
 508 
In conclusion, our data suggest that reduced food intake after rapid ascent to high 509 
altitudes was mediated by a variety of factors, which are still not completely 510 
understood. Reduced energy intake under hypoxic conditions at altitude was 511 
independently related to both reduced appetite before the meal and the presence of 512 
AMS symptoms. Altered food preferences were also present, although they were 513 
probably not the main drive. Changes in energy intake and food preferences were 514 
not related to altered secretion of gastrointestinal hormones under the current 515 
experimental conditions and, thus, the underlying mechanism by which hypoxia 516 
exerts its effects on appetite and eating behavior remains uncertain. One possible 517 
mechanism which was not explored here would be a reduction of appetite mediated 518 
by elevated serum leptin concentrations which have been found previously at high 519 
altitudes [35]. Furthermore, plasma sodium was found to be reduced in subjects 520 
suffering from AMS at high altitude as a result of reduced urine flow and thus a 521 
dilution through total body water [18]. However, whether this would directly affect 522 
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food intake or appetite or whether changes in sodium intake might affect severity of 523 
AMS was not studied. 524 
Treatment with Dexamethasone was an effective approach for reversing AMS 525 
symptoms and improving energy intake. Whether the prophylactic administration of 526 
steroids prior to ascent might help to prevent the early decrease in food intake, 527 
remains to be determined.  528 
These findings may also be relevant to understand the effects of hypoxia in other 529 
conditions. Using the model of high altitude studies for achieving a better 530 
understanding of the effect of hedonic and homeostatic systems in the control of 531 
appetite and energy intake in a hypoxic state might also help in the nutritional 532 
management of patients suffering from respiratory diseases, although it remains to 533 
be determined whether the mechanisms are truly comparable. 534 
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Table 1 Food stimuli used in the food preference questionnaires 
High-fat sweet Low-fat sweet High-fat savory Low-fat savory
Milk chocolate Jelly Babies French fries Salt sticks 
Brownies Fruit salad Chips Bread roll 
Cranberry Muffin Marshmallows Hard cheese Pasta with tomato 
sauce 
Shortbread Meringues Salami Wild rice mix 
Strawberry-cream-
cake 
Dried fruits Salted peanuts Boiled potatoes
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Table 2 Mean (± SD) Lake Louise Scores (LLS) as well as partial O2 (PaO2) and CO2 (PaCO2) 
pressure and arterial and peripheral O2 saturation (SaO2 and SpO2, respectively) grouped according to 
Dexamethasone treatment/ no treatment (n=11 in each group) 
 ZH MG2 MG4 
 Non-
treated 
treated Non-
treated 
treated Non-treated treated 
LLS score 0.9 ± 1.0 1.5 ± 1.21 3.4 ± 1.42 5.5 ± 2.31,2 2.3 ± 1.3 1.7 ± 0.93 
PaO2 (kPa)  12.2 ± 1.1 11.9 ± 2.3 5.4 ± 0.62 5.0 ± 0.42 5.8 ± 0.62,3 5.9 ± 0.62,3 
PaCO2 (kPa)  5.2 ± 0.4 5.0 ± 0.4 3.8 ± 0.32 3.7 ± 0.32 3.4 ± 0.42,3 3.3 ± 0.32,3 
SaO2 (%)  95.6 ± 0.7 94.1 ± 5.3 77.9 ± 5.42 73.7 ± 6.82 79.1 ± 5.12 80.6 ± 6.02,3 
SpO2 (%) 97.4 ± 1.5 96.9 ± 1.3 78.4 ± 6.02 73.1 ± 9.52 81.6 ± 8.62 79.5 ± 7.72 
1 significantly different from non-treated group (independent samples t-test, p<0.05) 
2 significantly different from ZH 
3 significantly different from MG2 
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Table 3 Hunger/satiety scores on a 100 mm visual analogue scale directly before (pre meal) and after 
(post meal) the ad libitum meal (n=22) 
 ZH MG2 MG4 
 pre meal post meal pre meal post meal pre meal post meal 
Hunger (mm) 59 ± 8 34 ± 7 43 ± 8 31 ± 7 64 ± 62 41 ± 72 
Desire to eat (mm) 58 ± 81 37 ± 7 40 ± 71 30 ± 7 65 ± 62 40 ± 72 
Amount of food (mm) 59 ± 7 42 ± 6 42 ± 61 33 ± 6 61 ± 52 42 ± 62 
1 significantly different compared to ZH (p<0.05) 
2 significantly different compared to MG2 (p<0.05) 
ZH: Zurich, low altitude, 446 m; MG2: Capanna Margherita day 2, first examination day at high 
altitude, 4559 m; MG4: Capanna Margherita day 4, second examination at high altitude 
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Table 4 Mean liking ratings on a 100 mm visual analogue scale and mean frequency of food choice 
for different food categories in a fasted state (before the preload) and after the ad libitum meal on all 
three examination days (n=22). 
 ZH MG2 MG4 
 pre meal post meal pre meal post meal pre meal post meal 
Liking score       
High-fat 42.0±22.1 21.7±14.83 34.5±17.0 21.6±15.43 46.1±19.62 27.6±15.23 
Low-fat 44.0±15.5 22.8±14.43 42.6±18.5 22.7±15.13 48.4±12.32 29.1±15.31,3 
Sweet 32.7±19.8 26.7±16.2 25.8±15.8 26.1±21.8 29.4±16.1 30.8±19.4 
Savoury 53.3±22.2 17.8±17.13 51.4±24.1 18.3±16.53 63.1±18.91,2 25.9±17.11,3 
Frequency of 
choice 
      
High-fat 28.4±5.1 32.1±4.13 28.4±5.8 30.1±4.21,3 28.4±5.82 30.3±4.51 
Low-fat 31.6±5.1 27.9±4.23 32.9±6.9 30.0±4.11,3 21.5±5.7 29.7±4.51 
Sweet 20.4±6.2 36.9±10.03 19.3±6.6 36.9±11.13 18.5±6.8 34.1±12.63 
Savoury 39.5±6.2 23.1±10.03 39.6±8.3 23.1±10.93 41.3±6.7 25.8±12.53 
1 significantly different compared to ZH (p<0.05), paired samples t-test 
2 significantly different compared to MG2 (p<0.05), paired samples t-test 
3 significantly different compared to pre meal on the same day (p<0.05), paired samples t-test 
ZH: Zurich, low altitude, 446 m; MG2: Capanna Margherita day 2, first examination day at high 
altitude, 4559 m; MG4: Capanna Margherita day 4, second examination at high altitude 
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Figure 1 Schedule of meals and blood sampling for each of the study days (ZH, MG2, MG4) 
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Figure 2 Difference in energy intake at the ad libitum dinner between subjects treated with 
Dexamethasone on the evening of MG2 (n=11) and untreated subjects (n=11). * indicates significant 
differences compared to the ‘Dexamethasone yes’ group (p<0.05); † indicates significant difference 
compared to MG4; ‡ indicates significant differences compare to ZH and MG4; the error bars are 
standard error of the mean. 
  
0
200
400
600
800
1000
1200
1400
ZH MG2 MG4
En
er
gy
 in
ta
ke
 (k
ca
l)
all subjects
Dexamethasone yes
Dexamethasone no
†
†
‡
*
‡ *
 33
 
 
 
 
Figure 3 Plasma concentrations of glucagon, amylin, peptide tyrosine tyrosine (PYY) and 
cholecystokinin (CCK) over the entire study day at the different examination days in healthy subjects 
(n=19-21). Zurich: low altitude, 446 m; MG2: Capanna Margherita day 2, first examination day at high 
altitude, 4559 m; MG4: Capanna Margherita day 4, second examination at high altitude; n=21 
 
